IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE - Italy 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:700-800
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:> 1000
Total Number of Projects:68
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:23
2011
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:200-300
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:500-600
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:100-200
Total Number of Projects:500-600
Total Project Funding:500-600
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Total Project Funding:300-400
Networking Rank (Reputation):600-700
Partner Constancy:400-500
Project Leadership Index:400-500
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 31
As coordinator: 1
As participant: 19
Sole participant: 11
Coordinator / Participant Ratio: 0.05*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 2.649.823 259.438 1
2021 321.473 3.694.189 321.473 2 1
2020 183.473 0 70.714 1
2019 2.497.500 4.011.939 2.759.000 1 1
2018 168.277 3.605.245 426.339 1 1
2017 2.619.527 149.950 2.769.477 2 1
2016 348.554 5.981.519 2.597.866 2 2
2015 149.425 10.966.184 718.736 1 2
2014 0 1.999.800 1.999.800 1
2013 0 15.066.041 3.279.881 4
2012 188.612 7.452.001 809.879 1 2
2011 179.584 4.622.400 4.801.984 1 2
2010 0 11.997.580 463.700 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE5
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS3
KAROLINSKA INSTITUTE3
UNIVERSITAET ZU KOELN3
UNIVERSITY OF COPENHAGEN3
ATLAS BIOLABS2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CONSIGLIO NAZIONALE DELLE RICERCHE2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
UNIVERSIDAD AUTONOMA DE MADRID2
UNIVERSITE DE GENEVE2
3RDPLACE1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACCELERON MEDICINES1
AMC MEDICAL RESEARCH BV1
ANAXOMICS BIOTECH S L1
BIOCONTRACT SP ZOO1
BIOMEDCODE ELLAS ANONIMI ETERIA EPISTIMONIKIS KAI TEXNOLOGIKIS EREVNASKAI EMBORIKIS EKMETALLEFSIS EPHARMOGON IATRIKIS1
BIOMEDCODE HELLAS1
BIOTECTURE1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE1
CENTRE FOR PROCESS INNOVATION LIMITED1
CORETHERAPIX SL1
COSMOPHOS1
DANDO WEISS & COLUCCI LIMITED1
ELEVATE BV1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ETAIRIA DIACHIRISIS KAI ANAPTIXIS EPISTIMONIKOU KAI TECHNOLOGIKOU PARKOU KRITIS AE1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS1
EURAM LIMITED1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
FAKULTNI NEMOCNICE U SV ANNY V BRNE1
FIBERTECH CO1
FONDATION DU CENTRE PLURIDISCIPLINAIRE D'ONCOLOGIE1
FONDAZIONE SANTA LUCIA1
FONDAZIONE TELETHON1
FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH1
FREIE UNIVERSITAET BERLIN1
FUJIKURA EUROPE1
FUNDACAO CALOUSTE GULBENKIAN1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III1
GALCHIMIA1
GENEVIA TECHNOLOGIES OY1
GENOMIC VISION1
GENXPRO1
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG1
HMGBIOTECH S R L1
IBM RESEARCH1
IMMUNOWELL FOUNDATION1
INNOVATION ACTA1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE1
IRCCS ASSOCIAZIONE LA NOSTRA FAMIGLIA 'ISTITUTO SCIENTIFICO EUGENIO MEDEA'1
ISTITUTO EUROPEO DI ONCOLOGIA1
ITAE SUOMEN YLIOPISTO1
ITALFARMACO1
JENLAB1
KANCERA AB1
KAROLINSKA INSTITUTET1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KING'S COLLEGE LONDON1
KLINIKUM DER UNIVERSITAET ZU KOELN1
KNIME1
KOBENHAVNS UNIVERSITET1
KRAEFTENS BEKAEMPELSE1
KUOPIO UNIVERSITY HOSPITAL1
LAVISION BIOTEC1
LEIBNIZINSTITUT FUR ALTERNSFORSCHUNG FRITZLIPMANNINSTITUT EV LEIBNIZ INSTITUTE ON AGING FRITZ LIPMANN INSTITUTE EV1
LGAI TECHNOLOGICAL CENTER1
LIVERPOOL JOHN MOORES UNIVERSITY1
LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
LUMICKS BV1
LXREPAIR1
MAGYAR TUDOMANYOS AKADEMIA SZEGEDIBIOLOGIAI KUTATOKOZPONT1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MIDATECH1
MIDATECH PHARMA ESPANA SL1
MISVIK BIOLOGY OY1
MOSAIQUES DIAGNOSTICS1
NANOLOGICA AB1
NATIONAL HELLENIC RESEARCH FOUNDATION1
NATIONAL UNIVERSITY OF IRELAND GALWAY1
NBIC / DTL DATA PROJECTS1
NORGENOTECH AS1
NOVARTIS PHARMA1
PANEPISTIMIO KRITIS1
PLASTICELL LIMITED1
PROCHIMIA SURFACES SP Z OO1
REDOXIS AB1
RUPRECHT KARLS UNIVERSITAET HEIDELBERG1
SANTHERA PHARMACEUTICALS1
SCUOLA INTERNAZIONALE SUPERIORE DI STUDI AVANZATI1
SEMMELWEIS EGYETEM1
STICHTING KATHOLIEKE UNIVERSITEIT1

Constancy:

Total number of partners: 157
Partner loyalty:
Frequent Partner: (> 2 projects): 17
Rare Partner: 140
Frequent / Rare Partner Ratio: 0.12

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Cohesin and its regulators: from chromosome dynamics and nuclear architecture to human diseases CohesiNetparticipant2.649.82320
2021-07-01INVESTIGATING THE IMPACT OF NUTRITIONAL METABOLISM ON DNA DAMAGE REPAIR IN CANCER METAREPAIRcoordinator171.4731
2021-07-01OrganVision: Technology for real-time visualizing and modelling of fundamental process in living organoids towards new insights into organ-specific health, disease, and recovery OrganVisionparticipant3.694.1898
2021-01-01Pharmacological inhibition of macrophage activation FIREQUENCHERcoordinator150.0001
2020-12-01Genetic determinants promoting resistance to BCR-loss in B-cell lymphomas BCRlossToBWinnercoordinator183.4732
2019-10-01The role of damage-induced non coding RNA in the control of DNA damage response activation at telomeres in aging TeloRNAgingcoordinator2.497.5001
2019-03-01Joint Training and Research Program on Chromatin Dynamics and the DNA Damage Response aDDRessparticipant4.011.93919
2018-06-01Dynamic and Mechanical Role of Spectrin in Membrane-Cytoskeleton Interplay MechanoSpectrincoordinator168.2771
2018-01-01COmbatting disorders of adaptive immunity with Systems MedICine COSMICparticipant3.605.24518
2017-09-01Inherited disfunctions of brain microcirculation V-EPCcoordinator2.451.2501
2017-07-01Regulation and reprogramming of alternative splicing in cellular transformation SPLICANCERcoordinator168.2771
2017-03-01The role of non coding RNA in organismal ageing RNAgingparticipant149.9501
2016-09-01Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network SYNTRAINparticipant3.990.26913
2016-07-01Mechanisms and regulators coordinating replication integrity and DNA damage tolerance. REPSUMODDTparticipant1.991.2501
2016-04-01Crosstalk between nuclear envelope and DNA Damage Response: Role of nucleoporin TPR in the maintenance of genomic integrity ENVERESPcoordinator168.2771
2016-04-01ATR-mediated mechanotransduction and connections with the actin cytoskeleton MECHANOCHECKcoordinator180.2771
2015-09-01Brain barriers training BtRAINparticipant3.067.40211
2015-06-01DDRNA-based cancer therapy targeted telomeres DDRNAcoordinator149.4251
2015-02-01The Development of Medium- and Large-Scale Sustainable Manufacturing Process Platforms for Clinically Compliant Solid Core Nanopharmaceuticals NANOFACTURINGparticipant7.898.7829
2014-06-01The role of essential DNA metabolism genes in vertebrate chromosome replication DNAMEREPparticipant1.999.8001
2013-07-017kDa TSLP as a novel type of anti-inflammatory agent to re-establish immune homeostasis 7TREIMHOparticipant146.9172
2013-06-01A novel direct role of non coding RNA in DNA damage response activation DDRNAparticipant2.329.2001
2013-03-01Novel nanotechnology-enabled system for endovascular in vivo near-infrared fluorescence molecular imaging and endovascular near-infrared targeted photodynamic therapy of atherosclerotic heart disease COSMOPHOS-NANOparticipant8.503.35219
2013-01-01Vascular Endothelial interactionS and SpEciaLization VESSELparticipant4.086.5729
2012-10-01Joint training and research network on Chromatin Dynamics and the DNA Damage Response ADDRESSparticipant3.804.29410
2012-10-01The role of Chronic DNA damage in Ageing and Age-related pathology CodeAgeparticipant3.647.7079
2012-03-01Mechanisms coordinating chromosome replication with transcription REPTRAcoordinator188.6121
2011-08-01THE ENDOCYTIC AND CYTOSKELETAL MATRIX IN THE PLASTICITY OF TUMOR CELL INVASION AND MIGRATION The MetaEndoMatrixparticipant2.232.2001
2011-08-01Transcriptional regulation of endothelial blood brain barrier differentiation by Wnt signaling Wnt for brainparticipant2.390.2001
2011-03-01Targeting of DNA deaminase AID via transcription and the RNA pol II elongation complex AID Recruitmentcoordinator179.5841
2010-01-01Activation of vasculature associated stem cells and muscle stem cells for the repair and maintenance of muscle tissue Endostemparticipant11.997.58022

Alias institution names:

  • IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE
  • IFOMISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS